Correlation Between Hookipa Pharma and RenovoRx
Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and RenovoRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and RenovoRx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hookipa Pharma and RenovoRx, you can compare the effects of market volatilities on Hookipa Pharma and RenovoRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of RenovoRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and RenovoRx.
Diversification Opportunities for Hookipa Pharma and RenovoRx
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Hookipa and RenovoRx is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and RenovoRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RenovoRx and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with RenovoRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RenovoRx has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and RenovoRx go up and down completely randomly.
Pair Corralation between Hookipa Pharma and RenovoRx
Given the investment horizon of 90 days Hookipa Pharma is expected to under-perform the RenovoRx. In addition to that, Hookipa Pharma is 1.28 times more volatile than RenovoRx. It trades about -0.48 of its total potential returns per unit of risk. RenovoRx is currently generating about 0.29 per unit of volatility. If you would invest 98.00 in RenovoRx on August 28, 2024 and sell it today you would earn a total of 23.00 from holding RenovoRx or generate 23.47% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Hookipa Pharma vs. RenovoRx
Performance |
Timeline |
Hookipa Pharma |
RenovoRx |
Hookipa Pharma and RenovoRx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Hookipa Pharma and RenovoRx
The main advantage of trading using opposite Hookipa Pharma and RenovoRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, RenovoRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RenovoRx will offset losses from the drop in RenovoRx's long position.Hookipa Pharma vs. Mereo BioPharma Group | Hookipa Pharma vs. Terns Pharmaceuticals | Hookipa Pharma vs. PDS Biotechnology Corp | Hookipa Pharma vs. Inozyme Pharma |
RenovoRx vs. Eliem Therapeutics | RenovoRx vs. HCW Biologics | RenovoRx vs. Scpharmaceuticals | RenovoRx vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
Stocks Directory Find actively traded stocks across global markets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |